U100:AU:AU-Global X US 100 ETF (AUD)

ETF | Others |

Last Closing

USD 15.55

Change

+0.05 (+0.32)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

-0.66 (-0.63%)

USD 17.87B
IVV:AU iShares Core S&P 500 AUD

-0.03 (-0.05%)

USD 11.24B
VGS:AU Vanguard MSCI International Sh..

-0.01 (-0.01%)

USD 10.01B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.11 (-0.18%)

USD 7.10B
IOZ:AU Ishares Core S&P/Asx 200

-0.21 (-0.62%)

USD 6.40B
STW:AU SPDR® S&P/ASX 200 Fund

-0.48 (-0.63%)

USD 5.57B
VTS:AU Vanguard US Total Market Share..

+0.03 (+0.01%)

USD 5.54B
NDQ:AU Betashares Nasdaq 100

-0.11 (-0.21%)

USD 5.22B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.03 (+0.07%)

USD 4.86B
A200:AU BetaShares Australia 200

-0.92 (-0.65%)

USD 4.72B

ETFs Containing U100:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.30% 56% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.30% 45% F 50% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike